Literature DB >> 29896862

Botulinum toxin type A for the first-line treatment of Hailey-Hailey disease.

Anita Kothapalli1,2, Tony Caccetta3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29896862     DOI： 10.1111/ajd.12852

Source DB:  PubMed          Journal:  Australas J Dermatol        ISSN： 0004-8380            Impact factor:   2.875


× No keyword cloud information.
  4 in total

Review 1.  Botulinum Toxin Use for Modulating Neuroimmune Cutaneous Activity in Psoriasis.

Authors:  Marius Nicolae Popescu; Cristina Beiu; Mădălina Gabriela Iliescu; Mara Mădălina Mihai; Liliana Gabriela Popa; Ana Maria Alexandra Stănescu; Mihai Berteanu
Journal:  Medicina (Kaunas)       Date:  2022-06-16       Impact factor: 2.948

Review 2.  Off-Label Use of Botulinum Toxin in Dermatology-Current State of the Art.

Authors:  Miłosz Lewandowski; Zuzanna Świerczewska; Wioletta Barańska-Rybak
Journal:  Molecules       Date:  2022-05-13       Impact factor: 4.927

3.  Therapeutic Use of Botulinum Neurotoxins in Dermatology: Systematic Review.

Authors:  Emanuela Martina; Federico Diotallevi; Giulia Radi; Anna Campanati; Annamaria Offidani
Journal:  Toxins (Basel)       Date:  2021-02-05       Impact factor: 4.546

4.  Botulinum Toxin Type A Injection Improves the Intraperitoneal High Pressure in Rats Treated with Abdominal Wall Plasty.

Authors:  Xue Zhang; Yingmo Shen; Shuo Yang; Baoshan Wang; Jie Chen
Journal:  Comput Intell Neurosci       Date:  2022-03-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.